[1]
“PHARMACOECONOMIC IMPACT OF POST–DEEP BRAIN STIMULATION MEDICATION USE AND ADVERSE EVENT PROFILE IN PATIENTS WITH PARKINSON’S DISEASE IN PAKISTAN”, FMHR, vol. 4, no. 6, pp. 320–330, Jun. 2026, Accessed: Jun. 09, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3063